Aurélie Schwarzbach has over 15 years of experience in the clinical research field. She is currently a senior project manager at Gamida Cell, a Jerusalem-based company, that she joined 7 years ago. She has been managing several clinical activities in studies of different phases, mainly Phase I-II and Phase III studies. More recently, she has orchestrated the clinical activities and documents preparation for the submission of a Biologics License Application (BLA) for omidubicel, an advanced cell therapy of Gamida Cell advanced cell therapies (www.gamida-cell.com).